Skip to main content
Top

Drugs

Issue 8/2022

Content (8 Articles)

New Topical Therapies in Development for Atopic Dermatitis

Egídio Freitas, Melinda Gooderham, Tiago Torres

Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside

Chiara Palandri, Lorenzo Santini, Alessia Argirò, Francesca Margara, Ruben Doste, Alfonso Bueno-Orovio, Iacopo Olivotto, Raffaele Coppini

Delafloxacin: A Review in Community-Acquired Pneumonia

Arnold Lee, Yvette N. Lamb, Matt Shirley

Nivolumab Plus Relatlimab: First Approval

Julia Paik

Ganaxolone: First Approval

Yvette N. Lamb

Olipudase Alfa: First Approval

  • AdisInsight Report

Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images